{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:23:43Z","timestamp":1768346623352,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010156","name":"Netherlands Leprosy Relief","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010137","name":"Fondation Sanofi Espoir","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010137","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ekir.2023.01.029","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T21:54:44Z","timestamp":1675202084000},"page":"796-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Increasing Serum Bicarbonate is Associated With Reduced Risk of Adverse Kidney Outcomes in Patients with CKD and Metabolic Acidosis"],"prefix":"10.1016","volume":"8","author":[{"given":"Navdeep","family":"Tangri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy L.","family":"Reaven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Funk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vandana","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"95","key":"10.1016\/j.ekir.2023.01.029_bib1","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1111\/j.1523-1755.2005.09503.x","article-title":"Risks of chronic metabolic acidosis in patients with chronic kidney disease","author":"Kopple","year":"2005","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.ekir.2023.01.029_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00467-010-1564-4","article-title":"Consequences and therapy of the metabolic acidosis of chronic kidney disease","volume":"26","author":"Kraut","year":"2011","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ekir.2023.01.029_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1471-2369-15-55","article-title":"Metabolic acidosis and the progression of chronic kidney disease","volume":"15","author":"Chen","year":"2014","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2023.01.029_bib4","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/ajcn\/68.3.576","article-title":"Estimation of net endogenous noncarbonic acid production in humans from diet potassium and protein contents","volume":"68","author":"Frassetto","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ekir.2023.01.029_bib5","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00150111","article-title":"Estimated net endogenous acid production and serum bicarbonate in African Americans with chronic kidney disease","volume":"6","author":"Scialla","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.01.029_bib6","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/ki.2010.348","article-title":"Acid retention during kidney failure induces endothelin and aldosterone production which lead to progressive GFR decline, a situation ameliorated by alkali diet","volume":"78","author":"Wesson","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.01.029_bib7","doi-asserted-by":"crossref","first-page":"F830","DOI":"10.1152\/ajprenal.00587.2010","article-title":"Acid retention accompanies reduced GFR in humans and increases plasma levels of endothelin and aldosterone","volume":"300","author":"Wesson","year":"2011","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.ekir.2023.01.029_bib8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ki.2012.267","article-title":"Angiotensin II receptors mediate increased distal nephron acidification caused by acid retention","volume":"82","author":"Wesson","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2023.01.029_bib9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1681\/ASN.2019070677","article-title":"Mechanisms of metabolic acidosis-induced kidney injury in chronic kidney disease","volume":"31","author":"Wesson","year":"2020","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.01.029_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1053\/j.ajkd.2009.02.014","article-title":"Serum bicarbonate levels and the progression of kidney disease: a cohort study","volume":"54","author":"Shah","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2023.01.029_bib11","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1053\/j.ajkd.2013.01.017","article-title":"Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the chronic renal insufficiency cohort (CRIC) study","volume":"62","author":"Dobre","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2023.01.029_bib12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1053\/j.ajkd.2010.03.023","article-title":"Serum bicarbonate and long-term outcomes in CKD","volume":"56","author":"Menon","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2023.01.029_bib13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12882-021-02385-z","article-title":"Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study","volume":"22","author":"Tangri","year":"2021","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2023.01.029_bib14","article-title":"Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): a report from the chronic renal insufficiency cohort (CRIC) study","volume":"4","author":"Dobre","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ekir.2023.01.029_bib15","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/nep.12315","article-title":"Prevalence of and risk factors for reduced serum bicarbonate in chronic kidney disease","volume":"19","author":"Raphael","year":"2014","journal-title":"Nephrol (Carlton)"},{"key":"10.1016\/j.ekir.2023.01.029_bib16","first-page":"93","article-title":"Dietary acid load is associated with serum bicarbonate but not insulin sensitivity in chronic kidney disease","volume":"26","author":"Ikizler","year":"2016","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.ekir.2023.01.029_bib17","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1377\/hlthaff.2014.0038","article-title":"Optum Labs: building a novel node in the learning health care system","volume":"33","author":"Wallace","year":"2014","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.ekir.2023.01.029_bib18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A\u00a0new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2023.01.029_bib19","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2215\/CJN.13091118","article-title":"Effects of treatment of metabolic acidosis in CKD: a systematic review and meta-analysis","volume":"14","author":"Navaneethan","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.01.029_bib20","unstructured":"Brinkman JE, Sharma S. Physiology, metabolic alkalosis. In: StatPearls [Internet]. StatPearls Publishing; 2022. Accessed January 20, 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482291\/"},{"key":"10.1016\/j.ekir.2023.01.029_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-048755","article-title":"Loop and thiazide diuretic use and risk of chronic kidney disease progression: a multicentre observational cohort study","volume":"12","author":"Fitzpatrick","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ekir.2023.01.029_bib22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0140-6736(19)31388-1","article-title":"Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension","volume":"394","author":"Wesson","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2023.01.029_bib24","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1681\/ASN.2015040369","article-title":"Ketoanalogue-supplemented vegetarian very low-protein diet and CKD progression","volume":"27","author":"Garneata","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2023.01.029_bib25","first-page":"gfac099","article-title":"Metabolic acidosis is undertreated and underdiagnosed: a retrospective cohort study","author":"Whitlock","year":"2022","journal-title":"Nephrol Dial Transplant"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024923000384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024923000384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T03:43:56Z","timestamp":1762832636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024923000384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2468024923000384"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2023.01.029","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increasing Serum Bicarbonate is Associated With Reduced Risk of Adverse Kidney Outcomes in Patients with CKD and Metabolic Acidosis","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2023.01.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}